Delivery Order SPE2DB22D9239-SPE2DB25FDL14
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $12,089.78 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Jakafi 20 mg tablets (60-count units). This firm fixed-price delivery order, issued on August 6, 2025, is due for completion by August 7, 2025, and carries no set-aside designation. DMS Pharmaceutical Group is performing under its larger Indefinite Delivery Contract with the DLA...
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Jakafi 10 mg tablets (60-count units). This firm fixed-price delivery order, valued at $12,115.65, was awarded on July 22, 2025, with an ultimate completion date of July 23, 2025. The award carries no set-aside designation and represents a single delivery order issued under DMS Pharmaceutical Group's larger...
- The Defense Logistics Agency awarded a delivery order valued at approximately $12.1K to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Jakafi 5 mg tablets (60-count units). The contract carries a firm fixed-price structure with no set-aside designation and an ultimate completion date of July 31, 2025. This delivery order was issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Jakafi 10 mg tablets (60-count units). This $12,115.65 firm fixed-price delivery order was awarded on July 14, 2025, with an ultimate completion date of July 15, 2025, and is not designated as a set-aside contract. The delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $16,285.24 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Jakafi 10 mg tablets (60-count units). This firm fixed-price delivery order, awarded on September 8, 2025, with an ultimate completion date of September 9, 2025, was issued without a set-aside designation. The contract is executed under DMS Pharmaceutical Group's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Jakafi 5 mg tablets (60-count units) under firm fixed-price terms. The contract, valued at $12,146.79 with an ultimate completion date of September 22, 2025, was awarded on September 19, 2025, with no set-aside designation applied. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,146.79 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Jakafi 5 mg tablets (60-count units). The contract, awarded on September 9, 2025, with an ultimate completion date of September 10, 2025, represents a firm fixed-price delivery order with no set-aside designation applied. This award falls under DMS Pharmaceutical Group's larger...
- The Defense Logistics Agency awarded a delivery order valued at $24,293.60 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Jakafi 5 mg tablets (60-count units). This firm fixed-price delivery order was awarded on July 18, 2025, with an ultimate completion date of July 21, 2025, and carries no set-aside designation. The award falls under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $36,440.37 to DMS Pharmaceutical Group Inc. for the supply of Jakafi 5 mg tablets (60-count units). DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform this contract at its Park Ridge facility with an ultimate completion date of July 9, 2025. This delivery order was awarded without a set-aside designation on July 8, 2025. This...
- The Defense Logistics Agency awarded a delivery order valued at $12,115.65 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Jakafi 10 mg tablets (60-count units). This firm fixed-price delivery order, issued on August 1, 2025, with an ultimate completion date of August 4, 2025, represents a direct pharmaceutical supply transaction under DLA's established procurement framework. The contract carries no...
- SPE2DB22D9239Indefinite Delivery Contract
- SPE2DB22D9239-SPE2DB25FDL14Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $60,578.25 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Jakafi 10 mg tablets (60-count units). Issued on August 18, 2025, with an ultimate completion date of August 19, 2025, this firm fixed-price delivery order carries no set-aside designation. The contract represents a specific product draw against DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, which carries a total value of approximately $500 million and remains valid through November 2026. DMS Pharmaceutical Group serves as a critical supplier within the federal pharmaceutical supply chain, leveraging its IDC to deliver prescription medications and medical supplies to Department of Defense healthcare facilities nationwide. The company has demonstrated consistent success in securing federal pharmaceutical contracts across a diverse product portfolio, ranging from oncology treatments to vaccines and specialty medications. This delivery order for Jakafi—a medication used in the treatment of myelofibrosis and polycythemia vera—exemplifies the company's role in supporting military health facility pharmaceutical needs through firm fixed-price delivery arrangements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $60.6k | 8/18/25 |